Close on 09 Oct 2026
All US Equities (S&P 500 / NASDAQ-100)

Bio-Techne

TECHUS Listed
Exchange: NYSE · Market: US Equities · Currency: USD

Bio-Techne (TECH) is a leading publicly traded corporation listed in the United States, constituent of the S&P 500 index.

Sector: Health Care·Indices: S&P 500
Close on 15 Oct 2026
$33.59
+0.61 (+1.85%)
Last updated: 15 Oct 2026 (US Market EOD settlement)

Stock Snapshot & Key Numbers — Bio-Techne

Verified Daily Close

Official closing price, 1-year price range, valuation multiples, and market value from exchange records.

Last Session Move
Up +1.85% on 15 Oct 2026
Position vs 1-Year High
20.8% below 52W High
P/E Valuation Multiple
18.0x (Under 20x)
Annual Cash Dividend
0.00% / No Recent Dividend
Close on 15 Oct 2026
$33.59
+0.61 (+1.85%)vs prev close
1-Year Low to High Range38% of range
Low: $28High: $42
Valuation (P/E, P/B & Dividend)
P/E Ratio (Price / Profit):18.0x
P/B Ratio (Price / Book):N/A
Dividend Yield:0.00%
Total Company Value (Market Cap)
—
Sector: Health Care
Latest Official Announcement:Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade
3d ago
Plain-English Company Summary

Bio-Techne (TECH) is a US equity security listed on the NYSE. As of the last recorded market session on Close on 15 Oct 2026, the stock closed at $33.59, recording a +0.61 (+1.85%) advance from its previous close of $32.98. Over the trailing 52-week trading cycle, TECH has traded between a 52-week low of $28.23 and a 52-week high of $42.41, establishing its annual trading channel. In historical performance, Bio-Techne has fallen 10.9% over the past 1 year. Period returns across standard measurement intervals include: 1-week: +10.2%, 1-month: +3.74%, 6-month: -1.58%, 1-year: -10.9%, 3-year: -15.39%, 5-year: -15.39%. Daily reported trading volume reached 100,586 equity shares. On key valuation multiples as of Oct 11, 2026, the company trades at a trailing price-to-earnings (P/E) multiple of 18.0x and a price-to-book (P/B) ratio of data unavailable, with a trailing dividend yield of 0.00%. Its market capitalization stands at —. The company is categorized under the Health Care sector and S&P 500 industry within the US equities universe.

Price Chart

1Y: -10.90% (₹-4.11)
₹42₹38₹33₹28Wed, 15 Oct, 2025Thu, 15 Oct, 2026

Trading Multiples & Ranges

Price boundaries and liquidity distribution.

52-Week Range$28.23 – $42.41
Low: $28.23High: $42.41
$28.23$42.41
Trailing P/E Ratio18.03x
Price to Book (P/B)—
Dividend Yield0.00%
Day High / Low$32.91 – $34.00
Daily Volume0.10M

Past Price Win/Loss Odds (1-Week, 1-Month, 3-Month)

How often this stock rose, stayed flat, or fell over past 21-day holding periods (based on historical data, not a future prediction).

1 Month Holding Period (21 trading days)
377 past 21-day periods analyzed
Fell 27.6%
Within ±5% (53.3%)
Rose 19.1%
Fell > 5%
27.6%
104 windows
Within ±5%
53.3%
201 windows
Rose > 5%
19.1%
72 windows
In 80% of past 1 month windows the move was within ±9.1%.
Historical outcomes of this stock's own price. Not a forecast. (398 trading days of history).
How to read historical odds

At-a-Glance Health & Momentum Check

Market Mood: Expansionary / Momentum
News Activity
STABLE
Recent announcement pace
Profit & Margin Trend
NEUTRAL
Earnings & margin direction
Economy Sensitivity
MODERATE
Impact of rates, oil & FX
Broad Market Mood
Expansionary / Momentum
Current market trend
News Tone
POSITIVE EXPANSION
Recent filing tone
What This Means(based on reported financials)

Company filings and balance-sheet numbers show steady day-to-day operations with stable margins and working capital.

Active Risk Flags & Monitoring Constraints
Standard systemic equity market and interest rate cycle exposure

How Outside Factors Affect This Stock (Market, Crude Oil & Currency)

How closely this stock moved with the broader market index, crude oil, and the exchange rate over the past year.

Swing Rank: 50th percentile
Typical 1-Year Price Swing (Volatility): 25.5% annualized
Price Swing Level vs Market: Moderate Swings
Factor / Benchmark1Y Beta (Sensitivity)1Y Correlation (-1 to +1)What This Means
S&P 500+0.16+0.08Trailing 1Y historical sensitivity: a 1% move in S&P 500 coincided with a +0.16% co-movement (correlation: 0.08). Descriptive historical relationship, not predictive.
US 10Y Treasury Yield-0.05-0.03Trailing 1Y historical sensitivity: a 1% move in US 10Y Treasury Yield coincided with a -0.05% co-movement (correlation: -0.03). Descriptive historical relationship, not predictive.
Brent Crude Oil-0.03-0.06Trailing 1Y historical sensitivity: a 1% move in Brent Crude Oil coincided with a -0.03% co-movement (correlation: -0.06). Descriptive historical relationship, not predictive.
USD / INR-0.67-0.19Trailing 1Y historical sensitivity: a 1% move in USD / INR coincided with a -0.67% co-movement (correlation: -0.19). Descriptive historical relationship, not predictive.
How to read Beta & Correlation ( Beta > 1 = wider swings than market; < 1 = calmer )▾

Sensitivities measure historical 1-year regression beta and correlation across paired daily trading sessions over the past 252 trading days. Past relationships can shift over time and do not guarantee future co-movement.

Trailing Returns Breakdown

Calendar-aligned historical percentage performance across standard market windows.

PeriodStart PriceCurrent PriceReturn (%)
1 Week₹30.48₹33.59+10.20%
15 Days₹30.53₹33.59+10.02%
1 Month₹32.38₹33.59+3.74%
3 Months₹31.08₹33.59+8.08%
6 Months₹34.13₹33.59-1.58%
1 Year₹37.70₹33.59-10.90%
3 Years₹39.70₹33.59-15.39%
5 Years₹39.70₹33.59-15.39%

Price Swings & Biggest Historical Drops

How much this stock typically fluctuates and its largest peak-to-bottom drops over 1 and 5 years.

1Y Yearly Swing
25.5%
Annualized volatility
1Y Beta vs Index
0.16
vs benchmark index
Biggest 1Y Drop
-33.4%
1Y peak-to-low drop
Biggest 5Y Drop
-33.4%
5Y peak-to-low drop
vs 52W High
-20.8%
Distance from 1Y high
vs 52W Low
+19.0%
Gain above 1Y low

Calendar-Year Historical Performance

Annual performance breakdown comparing first and last closing sessions of each calendar year.

Calendar YearStart CloseEnd CloseAnnual ReturnTrajectory Bar
CY 2026₹41.02₹33.59-18.1%
CY 2025₹39.70₹40.83+2.9%

Corporate Actions History

No dividend or stock split distributions recorded in historical feeds for TECH.

Historical Investment Simulator

Factual simulation of past returns in Bio-Techne (TECH) using real recorded closing prices.

₹1,00,000.00
5 Years
Principal Invested
₹1,00,000.00
₹1,00,000.00 starting capital
Portfolio Value Today
₹84,609.60
Based on latest close
Absolute Return
-15.4%
₹-15,390.40
Annualized (CAGR)
-9.8%
Compound annual growth
Entry Price: ₹39.70 · Exit Price: ₹33.59
Simulated 5Y period (INR)

Recent News & Official Exchange Announcements

Official exchange filings, order wins, and company updates. Click any announcement to see how it affects the business on the right.

Showing 2 of 2 Updates
#1 GENERALLODR Materiality: 68/100Neutral / RoutineRecent EventDirect Mention
3d ago

Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade

Ademi LLP investigates Bio-Techne sale to Merck KGaA scanx.trade

Valuation Impact:±0.5% (Neutral Fundamental Range)
Inspecting in Causal Panel
Source: scanx.trade·Horizon: SHORT_TERM
SEBI LODR Reg 30 Mapped
#2 EXPANSION CAPEXLODR Materiality: 89/100Positive Business DriverBackground Context
3mo ago

Merck KGaA agrees $11.3bn deal in major life sciences expansion - Life Sciences IP Review

Merck KGaA agrees $11.3bn deal in major life sciences expansion Life Sciences IP Review

Valuation Impact:+2.0% to +4.5% (Productive Capacity Accretion)
Outlay:₹93,790 Cr
Click to analyze
Source: Life Sciences IP Review·Horizon: LONG_TERM
SEBI LODR Reg 30 Mapped

Why This Matters for the Business

Plain-English breakdown of how the selected announcement connects to revenue, costs, and business drivers.

Event 1 of 2
Causal Attribution in Focus
GENERAL·3d ago
Verified Exchange / Wire Disclosure:
Ademi LLP investigates Bio-Techne sale to Merck KGaA - scanx.trade
Source: scanx.trade·LODR Materiality: 68/100
3-Stage Transmission Mechanism:
1. Disclosure Trigger
Regulatory & Corporate Disclosure Event
2. Sector Transmission
Sector-wide volume demand absorption & operating leverage
3. TECH Accretion
±0.5% (Neutral Fundamental Range)
Causal Attribution Analysis:Direct Named Awardee

Institutional regulatory disclosure or industry observation

Extracted Factual Evidence:
  • •Verified against public financial wire feeds and exchange disclosures
P&L Operating Leverage

Volume throughput absorbs fixed manufacturing plant overheads, supporting operating EBITDA margins and cash generation across health care units.

Order Book & Revenue Visibility

Continuous commercial tenders and capital expenditures lock in forward order book-to-bill expansion.

Affected Financial Metrics:
Enterprise Valuation MultiplesMarket Liquidity
Cross-asset macro betas (Brent Crude, USD/INR, NIFTY) are mapped in the dedicated dependency engine.
View Graph
Evidence Integrity: Hypotheses and attribution models are anchored strictly in verified regulatory disclosures, public tenders, and audited financial statements across a trailing 6-month capital cycle.

Common Questions About Bio-Techne (TECH)

Key facts on TECH share price, historical returns, valuation ratios, and past SIP performance.

What is the current share price and 52-week range of Bio-Techne (TECH)?

As of 15 Oct 2026, the official closing share price of Bio-Techne (TECH) on NYSE is $33.59 (+1.85% vs the previous close). Over the past 52 weeks, TECH has traded between a low of $28.23 and a high of $42.41, with a reported market capitalization of —.

What are the historical returns of Bio-Techne (TECH)?

Based on split-adjusted closing prices through 15 Oct 2026, Bio-Techne (TECH) recorded the following trailing price returns: 1 Week: +10.20% (from $30.48 to $33.59); 15 Days: +10.02% (from $30.53 to $33.59); 1 Month: +3.74% (from $32.38 to $33.59); 3 Months: +8.08% (from $31.08 to $33.59); 6 Months: -1.58% (from $34.13 to $33.59); 1 Year: -10.90% (from $37.70 to $33.59); 3 Years: -15.39% (from $39.70 to $33.59); 5 Years: -15.39% (from $39.70 to $33.59). Past performance reflects historical exchange records and does not predict future returns.

What is the P/E ratio, P/B ratio, and dividend yield of Bio-Techne (TECH)?

Bio-Techne (TECH) currently trades at a trailing Price-to-Earnings (P/E) ratio of 18.0x, a Price-to-Book (P/B) ratio of not reported, and a trailing 12-month dividend yield of 0.00%. It operates in the Health Care sector (S&P 500).

How much would a past lump-sum or monthly SIP investment in TECH have grown?

Based on historical closing prices for Bio-Techne (TECH): A one-time lump-sum investment of $10000.00 held for 5 years would be worth $8460.96 (-15.4% total return, -9.8% CAGR), while a monthly SIP of $500.00 over 5 years (total invested: $10000.00) would be worth $9374.10 (-6.3% absolute return). You can test custom amounts and holding periods in the interactive calculator above.